Skip to main content

Dispensing Biotechnology Products: Handling, Professional Education, and Product Information

  • Chapter
  • First Online:
Pharmaceutical Biotechnology

Abstract

Preparation, dispensing, and patient education regarding appropriate use of pharmaceuticals are primarily the responsibility of the pharmacist. Traditionally, parenteral products have been available in ready-to-use containers or required dilution with water or saline prior to use with no other special handling requirements. Hospital pharmacists, in particular, have prepared and dispensed parenteral products for individual patients for many years. While many pharmacists are skilled in handling parenteral products, biotechnology products present additional challenges since they are proteins subject to denaturation and thus require special handling techniques. These challenges will be explained in greater detail in this chapter. Practice issues with biotechnology products may be handled in slightly different ways depending on laws and pharmacy practice standards in each country. This chapter is written primarily from the view of practice in the United States since that is the primary experience of the authors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abbott Laboratories (2011) Humira® full prescribing information. North Chicago

    Google Scholar 

  • American Society of Health-System Pharmacists (2000) ASHP guidelines on quality assurance for pharmacy-prepared sterile products. Am J Health Syst Pharm 57(12):1150–1169

    Google Scholar 

  • Amgen Inc. (2007) Neupogen® full prescribing information. Thousand Oaks

    Google Scholar 

  • Amgen Inc. (2011) Epogen® full prescribing information. Thousand Oaks

    Google Scholar 

  • Banga AK, Reddy IK (1994) Biotechnology drugs: pharmaceutical issues. Pharm Times 60:68–76

    Google Scholar 

  • Bayer HealthCare (2010) Betaseron® full prescribing information. Montville

    Google Scholar 

  • Caremark (2006) Trends Rx Report, Focus on specialty pharmacy. Northbrook

    Google Scholar 

  • Catania P (2010) King guide to parenteral admixture. King Guide Publications, Inc. St Louis

    Google Scholar 

  • Department of Health and Human Services (2010) CMS manual system, Pub 100–02 Medicare Benefit Policy, Transmittal 123

    Google Scholar 

  • Fein AJ (2010) 2010–11 Economic report on retail and specialty pharmacies. Pembroke Consulting, Philadelphia

    Google Scholar 

  • Genentech, Inc. (1994) Pulmozyme® full prescribing information. South San Francisco

    Google Scholar 

  • Genentech, Inc. (2011) Activase® full prescribing information. South San Francisco

    Google Scholar 

  • Genzyme Corporation (2009) Leukine® full prescribing information. Cambridge

    Google Scholar 

  • Koeller J, Fields S (1991) The pharmacist’s role with biotechnology products. The Upjohn Company, Kalamazoo

    Google Scholar 

  • McDermott DF, Regan MM, Clark JI et al (2005) Randomized phase III trial of high-dose interleukin-2 versus subcutaneous interleukin-2 and interferon in patients with metastatic renal cell carcinoma. J Clin Oncol 23(1):133–141

    Article  PubMed  CAS  Google Scholar 

  • McEvoy GK (2011) American hospital formulary service drug information. American Society of Health-System Pharmacists, Bethesda

    Google Scholar 

  • Prometheus Therapeutics (2011) Proleukin® full prescribing information. Emeryville

    Google Scholar 

  • Roche Laboratories (2005) Summary of product characteristics. Accessed at: http://www.rocheuk.com/ProductDB/Documents/rx/spc/Roferon-A_Cartridge_SPC.pdf. Accessed 31 Oct 2006

  • Schering Laboratories (2004) Intron® full prescribing information. Kenilworth, Schering Laboratories

    Google Scholar 

  • Suchanek D (2005) The rise and role of specialty pharmacy. Biotechnol Healthc 2:31–35

    PubMed  Google Scholar 

Further Reading

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peggy Piascik Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Piascik, P., Adams, V. (2013). Dispensing Biotechnology Products: Handling, Professional Education, and Product Information. In: Crommelin, D., Sindelar, R., Meibohm, B. (eds) Pharmaceutical Biotechnology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6486-0_9

Download citation

Publish with us

Policies and ethics